"Lymph Node Excision" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966)
| Descriptor ID |
D008197
|
| MeSH Number(s) |
E04.446
|
| Concept/Terms |
Lymph Node Excision- Lymph Node Excision
- Excision, Lymph Node
- Excisions, Lymph Node
- Lymph Node Excisions
- Lymphadenectomy
- Lymphadenectomies
Lymph Node Dissection- Lymph Node Dissection
- Dissection, Lymph Node
- Dissections, Lymph Node
- Lymph Node Dissections
- Node Dissection, Lymph
- Node Dissections, Lymph
|
Below are MeSH descriptors whose meaning is more general than "Lymph Node Excision".
Below are MeSH descriptors whose meaning is more specific than "Lymph Node Excision".
This graph shows the total number of publications written about "Lymph Node Excision" by people in this website by year, and whether "Lymph Node Excision" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 3 | 4 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 5 | 6 |
| 2004 | 3 | 0 | 3 |
| 2005 | 2 | 3 | 5 |
| 2006 | 2 | 0 | 2 |
| 2007 | 5 | 2 | 7 |
| 2008 | 4 | 1 | 5 |
| 2009 | 6 | 2 | 8 |
| 2010 | 5 | 0 | 5 |
| 2012 | 7 | 4 | 11 |
| 2013 | 7 | 7 | 14 |
| 2014 | 0 | 4 | 4 |
| 2015 | 5 | 4 | 9 |
| 2016 | 7 | 4 | 11 |
| 2017 | 6 | 7 | 13 |
| 2018 | 6 | 3 | 9 |
| 2019 | 6 | 7 | 13 |
| 2020 | 3 | 5 | 8 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 5 | 5 |
| 2023 | 1 | 7 | 8 |
| 2024 | 3 | 1 | 4 |
| 2025 | 2 | 2 | 4 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymph Node Excision" by people in Profiles.
-
Robotic versus open post-chemotherapy retroperitoneal lymph node dissection: a propensity score matched study across 11 academic medical centers. World J Urol. 2026 Aug 28; 44(1).
-
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med. 2026 Apr 02; 394(13):1257-1269.
-
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial. Ann Surg Oncol. 2025 Oct; 32(11):8211-8219.
-
Treatment at Academic Facilities Is Associated With Improved Survival in Late-Stage Colonic Neuroendocrine Tumors. J Surg Res. 2025 06; 310:111-121.
-
Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial. J Urol. 2025 09; 214(3):272-279.
-
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial. Ann Surg Oncol. 2025 May; 32(5):3278-3291.
-
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour. BJU Int. 2025 Apr; 135(4):621-628.
-
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study. Eur Urol Focus. 2025 Mar; 11(2):266-272.
-
Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer. Am J Obstet Gynecol. 2025 Mar; 232(3):308.e1-308.e15.
-
Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy. Am Soc Clin Oncol Educ Book. 2024 Jun; 44(3):e438776.